特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
297187

ドラッグデリバリーにおけるナノテクノロジーの世界市場

Nanotechnology in Drug Delivery

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 145 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.70円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

ドラッグデリバリーにおけるナノテクノロジーの世界市場
出版日: 2020年07月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 145 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のドラッグデリバリーにおけるナノテクノロジー市場について調査し、市場の動向とセグメント別概要、地域別動向、および市場に参入主要企業のプロファイルと競合動向についてまとめています。

第1章 イントロダクション、調査方法、製品定義

第2章 エグゼクティブサマリー

  • 市場概要
    • ナノテクノロジー:医療改革の重要部分
    • ナノメディシン、医療の基礎部分の革命
    • ナノメディシンにおけるナノ粒子の役割
    • ナノテクノロジーを駆使したsiRNA
    • ナノエマルジョンが注目され始める
    • ますます重要な役割を果たすナノテクノロジー
    • 抗レトロウイルス療法に新たな道を開くナノテクノロジー
    • ナノテクノロジーによる中枢神経系治療薬のデリバリー
    • 市場見通し
    • 世界の競合他社の市場シェア
    • COVID-19の影響と迫り来る世界同時不況、など
  • 主要企業
    • AbbVie Inc. (USA)
    • Aquanova AG (Germany)
    • BlueWillow Biologics (USA)
    • Camurus AB (Sweden)
    • Celgene, Inc. (Canada)
    • Ceramisphere Health Pty Limited (Australia)
    • Cristal Therapeutics (The Netherlands)
    • CYTIMMUNE SCIENCES, INC. (Italy)
    • EnColl Corporation (USA)
    • EyePoint Pharmaceuticals (USA)
    • Lena Nanoceutics Ltd. (UK)
    • NanOlogy LLC (USA)
    • NanoCarrier Co., Ltd. (Japan)
    • Nanobiotix (France)
    • Nanospectra Biosciences, Inc (USA)
    • Parvus Therapeutics Inc. (USA)
    • Selecta Biosciences (USA)
    • Starpharma Holdings Limited (Australia)
    • Taiwan Liposome Co. (Taiwan)
    • Tarveda Therapeutics (USA)
  • 市場動向と成長要因
  • 世界市場の見通し

第3章 市場分析

  • 地域別市場見通し
  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • スペイン
    • ロシア
    • その他
  • アジア太平洋地域
    • オーストラリア
    • インド
    • 韓国
    • その他
  • ラテンアメリカ
    • アルゼンチン
    • ブラジル
    • メキシコ
    • その他
  • 中東
    • イラン
    • イスラエル
    • サウジアラビア
    • アラブ首長国連邦
    • その他
  • アフリカ

第4章 競合情報

目次
Product Code: MCP-7808

Global Nanotechnology in Drug Delivery Market to Reach $164.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Nanotechnology in Drug Delivery estimated at US$47.5 Billion in the year 2020, is projected to reach a revised size of US$164.1 Billion by 2027, growing at aCAGR of 19.4% over the period 2020-2027. Nanocrystals, one of the segments analyzed in the report, is projected to record 17.3% CAGR and reach US$83.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Nanocarriers segment is readjusted to a revised 21.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $12.8 Billion, While China is Forecast to Grow at 24.5% CAGR

The Nanotechnology in Drug Delivery market in the U.S. is estimated at US$12.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$38.8 Billion by the year 2027 trailing a CAGR of 24.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.2% and 17% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 15.2% CAGR.We bring years of research experience to this 15th edition of our report. The 145-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • AbbVie Inc.
  • Aquanova AG
  • BlueWillow Biologics
  • Camurus AB
  • Celgene, Inc.
  • Ceramisphere Health Pty Limited
  • Cristal Therapeutics
  • CYTIMMUNE SCIENCES, Inc.
  • EnColl Corporation
  • EyePoint Pharmaceuticals
  • Lena Nanoceutics Ltd.
  • Nanobiotix
  • NanoCarrier Co., Ltd.
  • NanOlogy LLC
  • Nanospectra Biosciences, Inc.
  • Parvus Therapeutics Inc.
  • Selecta Biosciences
  • Starpharma Holdings Limited
  • Taiwan Liposome Co.,
  • Tarveda Therapeutics

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Nanotechnology, A Critical Part of Healthcare Reform
  • Recent Market Activity
  • Nanomedicine, Revolutionizing the Basics of Medicine
  • A Peek Into the Evolving Role of Nanoparticles in Nanomedicine
  • Nanocrystals Continue to Gain Momentum as Alternatives to Traditional Nanocarriers
  • Nanocarriers Enable Targeted Drug Delivery Systems to Improve Therapeutic Outcomes
  • Advanced Liposomes Enable Low Soluble Drugs to Achieve Targeted Delivery
  • Multifunctional Dendrimers Present an Ideal Structure for Targeted Drug Delivery
  • High Drug Loading Capacity of PAMAM Dendrimers Bodes Well for Targeted Drug Delivery Systems
  • Nanotechnology-Based Strategies for siRNA Grows in Popularity
  • NEM Devices as Drug Delivery Vehicles
  • Nanotechnology - In Pursuit of Co-Delivery of Drugs
  • Nanoemulsions Begin to Make a Mark
  • Nanotechnology Finds Increasing Role in Fighting Infectious Diseases
  • List of Select Nanotechnology-based Antimicrobial Drugs in Clinical Use
  • Nanotechnology Opening New Avenues in Antiretroviral Therapy
  • Demonstrated Activity of Select Nanotechnology- Delivered Antiretroviral Therapies
  • Nanotechnology in Delivery of CNS Therapeutics
  • Market Outlook
  • Global Competitor Market Shares
  • Nanotechnology in Drug Delivery Competitor Market Share Scenario Worldwide (in %): 2020 & 2029
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

  • AbbVie Inc. (USA)
  • Aquanova AG (Germany)
  • BlueWillow Biologics (USA)
  • Camurus AB (Sweden)
  • Celgene, Inc. (Canada)
  • Ceramisphere Health Pty Limited (Australia)
  • Cristal Therapeutics (The Netherlands)
  • CYTIMMUNE SCIENCES, INC. (Italy)
  • EnColl Corporation (USA)
  • EyePoint Pharmaceuticals (USA)
  • Lena Nanoceutics Ltd. (UK)
  • NanOlogy LLC (USA)
  • NanoCarrier Co., Ltd. (Japan)
  • Nanobiotix (France)
  • Nanospectra Biosciences, Inc (USA)
  • Parvus Therapeutics Inc. (USA)
  • Selecta Biosciences (USA)
  • Starpharma Holdings Limited (Australia)
  • Taiwan Liposome Co. (Taiwan)
  • Tarveda Therapeutics (USA)

3. MARKET TRENDS & DRIVERS

  • Growing Need for Alternative Approaches to Conventional Chemotherapy Creates Opportunities for Nanoparticles
  • Stimuli Responsive Polymeric Micelles Promise Enhanced Therapeutic Effect for Hydrophobic Anticancer Drugs
  • Inorganic Nanocarriers Facilitate High Payload Capacity and Co-Delivery Platforms for MDR Cancer Therapy
  • Solid Lipid Nanoparticles Provide Increased Physical Stability in Targeted Drug Delivery
  • Pulmonary Delivery of Nanoparticle-Based Drugs Receives Increased Interest
  • Inhalable Liposome Formulations Attract Research Interest in Pulmonary Delivery
  • SLNs in Pulmonary Delivery of Drugs
  • Market Challenges
  • Increasing Environmental and Health Concerns
  • Limited Success and Scaling Up Issues Pose a Major Hurdle to Further Advancement
  • Higher Concentration of Research in Academia limits Commercialization
  • Collaborations Assume Importance
  • Nanomedicine Regulation

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Nanotechnology in Drug Delivery Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Nanotechnology in Drug Delivery Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
  • TABLE 3: Nanocrystals (Technology) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 4: Nanocrystals (Technology) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
  • TABLE 5: Nanocarriers (Technology) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 6: Nanocarriers (Technology) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Nanotechnology in Drug Delivery Market Share (in %) by Company: 2020 & 2025
    • Market Analytics
    • TABLE 7: Nanotechnology in Drug Delivery Market in US$ Million in the United States by Technology: 2020-2027
    • TABLE 8: United States Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027
  • CANADA
    • TABLE 9: Nanotechnology in Drug Delivery Market Analysis in Canada in US$ Million by Technology: 2020-2027
    • TABLE 10: Canadian Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027
  • JAPAN
    • TABLE 11: Japanese Medium & Long-Term Outlook for Nanotechnology in Drug Delivery Market in US$ Million by Technology: 2020-2027
    • TABLE 12: Japanese Nanotechnology in Drug Delivery Market Percentage Share Distribution by Technology: 2020 VS 2027
  • CHINA
    • TABLE 13: Nanotechnology in Drug Delivery Market Estimates and Forecasts in China in US$ Million by Technology: 2020-2027
    • TABLE 14: Nanotechnology in Drug Delivery Market in China: Percentage Share Analysis by Technology for 2020 and 2027
  • EUROPE
    • Market Facts & Figures
    • European Nanotechnology in Drug Delivery Market: Competitor Market Share Scenario (in %) for 2020 & 2025
    • Market Analytics
    • TABLE 15: European Nanotechnology in Drug Delivery Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 16: European Nanotechnology in Drug Delivery Market Share Shift by Region/Country: 2020 VS 2027
    • TABLE 17: European Nanotechnology in Drug Delivery Market Assessment in US$ Million by Technology: 2020-2027
    • TABLE 18: Nanotechnology in Drug Delivery Market in Europe: Percentage Breakdown of Sales by Technology for 2020 and 2027
  • FRANCE
    • TABLE 19: French Nanotechnology in Drug Delivery Market Estimates and Projections in US$ Million by Technology: 2020-2027
    • TABLE 20: French Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027
  • GERMANY
    • TABLE 21: German Nanotechnology in Drug Delivery Latent Demand Forecasts in US$ Million by Technology: 2020-2027
    • TABLE 22: German Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027
  • ITALY
    • TABLE 23: Nanotechnology in Drug Delivery Market Estimates and Forecasts in Italy in US$ Million by Technology: 2020-2027
    • TABLE 24: Nanotechnology in Drug Delivery Market in Italy: Percentage Share Analysis by Technology for 2020 and 2027
  • UNITED KINGDOM
    • TABLE 25: United Kingdom Medium & Long-Term Outlook for Nanotechnology in Drug Delivery Market in US$ Million by Technology: 2020-2027
    • TABLE 26: United Kingdom Nanotechnology in Drug Delivery Market Percentage Share Distribution by Technology: 2020 VS 2027
  • SPAIN
    • TABLE 27: Nanotechnology in Drug Delivery Market Analysis in Spain in US$ Million by Technology: 2020-2027
    • TABLE 28: Spanish Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027
  • RUSSIA
    • TABLE 29: Nanotechnology in Drug Delivery Market in US$ Million in Russia by Technology: 2020-2027
    • TABLE 30: Russian Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027
  • REST OF EUROPE
    • TABLE 31: Rest of Europe Nanotechnology in Drug Delivery Market Assessment in US$ Million by Technology: 2020-2027
    • TABLE 32: Nanotechnology in Drug Delivery Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2020 and 2027
  • ASIA-PACIFIC
    • TABLE 33: Asia-Pacific Nanotechnology in Drug Delivery Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 34: Asia-Pacific Nanotechnology in Drug Delivery Market Share Analysis by Region/Country: 2020 VS 2027
    • TABLE 35: Asia-Pacific Nanotechnology in Drug Delivery Market Estimates and Projections in US$ Million by Technology: 2020-2027
    • TABLE 36: Asia-Pacific Nanotechnology in Drug Delivery Historic Market Analysis in US$ Million by Technology: 2020 VS 2027
  • AUSTRALIA
    • TABLE 37: Australian Nanotechnology in Drug Delivery Latent Demand Forecasts in US$ Million by Technology: 2020-2027
    • TABLE 38: Australian Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027
  • INDIA
    • TABLE 39: Nanotechnology in Drug Delivery Market Analysis in India in US$ Million by Technology: 2020-2027
    • TABLE 40: Indian Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027
  • SOUTH KOREA
    • TABLE 41: Nanotechnology in Drug Delivery Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Technology for the Period 2020-2027
    • TABLE 42: Nanotechnology in Drug Delivery Market Share Distribution in South Korea by Technology: 2020 VS 2027
  • REST OF ASIA-PACIFIC
    • TABLE 43: Rest of Asia-Pacific Medium & Long-Term Outlook for Nanotechnology in Drug Delivery Market in US$ Million by Technology: 2020-2027
    • TABLE 44: Rest of Asia-Pacific Nanotechnology in Drug Delivery Market Percentage Share Distribution by Technology: 2020 VS 2027
  • LATIN AMERICA
    • TABLE 45: Latin American Nanotechnology in Drug Delivery Market Trends by Region/Country in US$ Million: 2020-2027
    • TABLE 46: Latin American Nanotechnology in Drug Delivery Market Percentage Breakdown of Sales by Region/Country: 2020 and 2027
    • TABLE 47: Nanotechnology in Drug Delivery Market Estimates and Forecasts in Latin America in US$ Million by Technology: 2020-2027
    • TABLE 48: Nanotechnology in Drug Delivery Market in Latin America : Percentage Analysis by Technology for 2020 and 2027
  • ARGENTINA
    • TABLE 49: Argentinean Nanotechnology in Drug Delivery Market Assessment in US$ Million by Technology: 2020-2027
    • TABLE 50: Nanotechnology in Drug Delivery Market in Argentina: Percentage Breakdown of Sales by Technology for 2020 and 2027
  • BRAZIL
    • TABLE 51: Brazilian Nanotechnology in Drug Delivery Market Estimates and Projections in US$ Million by Technology: 2020-2027
    • TABLE 52: Brazilian Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027
  • MEXICO
    • TABLE 53: Mexican Nanotechnology in Drug Delivery Latent Demand Forecasts in US$ Million by Technology: 2020-2027
    • TABLE 54: Mexican Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027
  • REST OF LATIN AMERICA
    • TABLE 55: Nanotechnology in Drug Delivery Market in US$ Million in Rest of Latin America by Technology: 2020-2027
    • TABLE 56: Rest of Latin America Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027
  • MIDDLE EAST
    • TABLE 57: The Middle East Nanotechnology in Drug Delivery Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 58: The Middle East Nanotechnology in Drug Delivery Market Share Breakdown by Region/Country: 2020 and 2027
    • TABLE 59: The Middle East Nanotechnology in Drug Delivery Market Analysis in US$ Million by Technology: 2020-2027
    • TABLE 60: The Middle East Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027
  • IRAN
    • TABLE 61: Iranian Medium & Long-Term Outlook for Nanotechnology in Drug Delivery Market in US$ Million by Technology: 2020-2027
    • TABLE 62: Iranian Nanotechnology in Drug Delivery Market Percentage Share Distribution by Technology: 2020 VS 2027
  • ISRAEL
    • TABLE 63: Israeli Nanotechnology in Drug Delivery Market Assessment in US$ Million by Technology: 2020-2027
    • TABLE 64: Nanotechnology in Drug Delivery Market in Israel: Percentage Breakdown of Sales by Technology for 2020 and 2027
  • SAUDI ARABIA
    • TABLE 65: Nanotechnology in Drug Delivery Market Estimates and Forecasts in Saudi Arabia in US$ Million by Technology: 2020-2027
    • TABLE 66: Nanotechnology in Drug Delivery Market in Saudi Arabia: Percentage Share Analysis by Technology for 2020 and 2027
  • UNITED ARAB EMIRATES
    • TABLE 67: Nanotechnology in Drug Delivery Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Technology for the Period 2020-2027
    • TABLE 68: Nanotechnology in Drug Delivery Market Share Distribution in United Arab Emirates by Technology: 2020 VS 2027
  • REST OF MIDDLE EAST
    • TABLE 69: Rest of Middle East Nanotechnology in Drug Delivery Latent Demand Forecasts in US$ Million by Technology: 2020-2027
    • TABLE 70: Rest of Middle East Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027
  • AFRICA
    • TABLE 71: Nanotechnology in Drug Delivery Market in US$ Million in Africa by Technology: 2020-2027
    • TABLE 72: African Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 43
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.